Drew Moghanaki shared a study from Duke University on Stage I NSCLC

Drew Moghanaki, Lung Cancer Specialist at UCLA Health Jonsson Cancer Center, shared a post on X/Twitter:

“An interdisciplinary group at Duke University recently compared the time to treatment for patients with Stage I Non-Small Cell Lung Cancer, who undergo a thoracic surgery evaluation or not.

At UCLA, the thoracic surgery team is spectacular at expediting work up to minimize the time it takes to start Stereotactic Body Radiotherapy (SBRT). (Not a typo)”

Read further.

Source: Drew Moghanaki/X